Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
7
58%
Ph phase_4
2
17%
Ph phase_3
2
17%
Ph phase_2
1
8%

Phase Distribution

0

Early Stage

1

Mid Stage

4

Late Stage

Phase Distribution12 total trials
Phase 2Efficacy & side effects
1(8.3%)
Phase 3Large-scale testing
2(16.7%)
Phase 4Post-market surveillance
2(16.7%)
N/ANon-phased studies
7(58.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

0

trials recruiting

Total Trials

12

all time

Status Distribution
Completed(5)
Terminated(2)
Other(5)

Detailed Status

unknown5
Completed5
Withdrawn2

Development Timeline

Analytics

Development Status

Total Trials
12
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (8.3%)
Phase 32 (16.7%)
Phase 42 (16.7%)
N/A7 (58.3%)

Trials by Status

unknown542%
completed542%
withdrawn217%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
DEVICE
Total Trials
12